| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |